Patients with muscular dystrophy who spend years in hospitals develop severe bone weakness, particularly in the hip area, according to a 2026 cross-sectional study of 32 long-term hospitalized patients. Gram Research analysis found these patients had hip bone density scores of -4.1 (indicating severe osteoporosis) and vitamin D levels averaging 18.8 ng/mL, well below the healthy range of 30 ng/mL or higher. The prolonged immobility from wheelchair dependence or bed confinement appears to accelerate bone loss in this vulnerable population.
A new study looked at 32 patients with muscular dystrophy who spent years in the hospital and found they developed serious bone weakness, especially in their hips. According to Gram Research analysis, these patients had very low vitamin D levels and weak bones in their hip area, even though their spine bones were somewhat stronger. The research shows that when people with muscular dystrophy can’t move around for long periods, their bones break down faster than normal. This discovery could help doctors create better treatment plans to protect the bones of patients who need long-term hospital care.
Key Statistics
A 2026 cross-sectional study of 32 long-term hospitalized muscular dystrophy patients found median hip bone density T-scores of -4.1, indicating severe osteoporosis, compared to spine T-scores of -2.2.
According to research reviewed by Gram, 100% of the 32 long-term hospitalized muscular dystrophy patients studied had vitamin D levels averaging 18.8 ng/mL, below the 30 ng/mL threshold for adequate vitamin D status.
A 2026 study found that muscular dystrophy patients hospitalized for a median of 2,287 days (over 6 years) showed markedly reduced femoral neck bone mineral density with minimal changes in bone breakdown markers, suggesting gradual bone loss over time.
Research from 2026 showed that long-term hospitalized muscular dystrophy patients had serum albumin levels of 3.5 g/dL, slightly below normal, which may contribute to impaired bone structure and strength.
The Quick Take
- What they studied: Whether patients with muscular dystrophy who stay in hospitals for very long periods develop weak bones and poor bone health
- Who participated: 32 patients with muscular dystrophy (average age 50 years) who had been hospitalized for an average of over 6 years and were either wheelchair-dependent or bedbound
- Key finding: Patients had severely weak hip bones (femoral neck T-score of -4.1) and very low vitamin D levels (18.8 ng/mL), while spine bones were less affected
- What it means for you: If you or a loved one has muscular dystrophy and requires long-term hospitalization, doctors should monitor bone health closely and ensure adequate vitamin D intake. However, this study is small and observational, so more research is needed before making major treatment changes.
The Research Details
This was a retrospective cross-sectional study, which means researchers looked back at medical records of patients who had already been treated. They examined 32 patients with muscular dystrophy who had spent extended time in the hospital (ranging from about 2 to 46 years). The researchers measured bone density using a special imaging test and checked blood levels of important bone-building nutrients like calcium, vitamin D, and proteins that indicate how fast bones are breaking down.
The study design allowed researchers to take a snapshot of bone health at one point in time rather than following patients over months or years. This approach is useful for identifying problems but doesn’t prove that hospitalization directly caused the bone weakness—it just shows the two conditions exist together in this group.
Understanding bone health in long-term hospitalized patients with muscular dystrophy is important because these patients face a double challenge: their muscles are already weak from their disease, and lying in bed or sitting in wheelchairs for years can make bones even weaker. This research helps doctors recognize a hidden problem that might not be obvious without testing.
This study has some important limitations to consider. The sample size is relatively small (32 patients), which means the findings may not apply to all patients with muscular dystrophy. The study is observational rather than experimental, so it shows associations but cannot prove cause-and-effect. The researchers did not have a comparison group of patients without muscular dystrophy or with shorter hospital stays, making it harder to know how much of the bone weakness is due to the disease versus hospitalization. However, the study does provide valuable real-world data from actual patient records.
What the Results Show
The study found that patients with muscular dystrophy who spent years in hospitals had dramatically weak hip bones. The hip bone density score was -4.1, which is well below the normal range and indicates severe osteoporosis (very weak bones). In contrast, spine bone density was less severely affected, with a score of -2.2. This difference is important because it suggests that lack of movement affects different parts of the skeleton differently.
Vitamin D levels were also concerning. The average vitamin D level was 18.8 ng/mL, which is considered insufficient or deficient (normal is above 30 ng/mL). Vitamin D is crucial for bone health because it helps the body absorb calcium. Surprisingly, blood calcium levels were mostly normal, and markers showing how fast bones were breaking down were also within normal ranges, suggesting the body was trying to maintain calcium balance even as bones weakened.
Protein levels (measured by serum albumin) were slightly low at 3.5 g/dL, which could contribute to bone weakness since protein is needed to build bone structure. The bone breakdown markers (TRACP-5b and BAP) were within normal ranges, which was unexpected and suggests the bones may not be actively breaking down at an accelerated rate despite being weak. This pattern indicates the bone weakness may have developed gradually over years rather than from rapid recent bone loss.
Previous research has shown that immobility and lack of weight-bearing exercise cause bone loss in many conditions, including spinal cord injury and prolonged bed rest. This study confirms that muscular dystrophy patients experience similar bone loss patterns, particularly in weight-bearing areas like the hip. The finding of low vitamin D is consistent with other studies of hospitalized patients, who often have limited sun exposure. However, this is one of the first studies to specifically examine bone health in long-term hospitalized muscular dystrophy patients, filling an important gap in medical knowledge.
The study has several important limitations. First, it’s small with only 32 patients, so results may not apply to all muscular dystrophy patients. Second, there’s no comparison group, so we can’t know exactly how much bone loss is from the disease versus hospitalization. Third, the study looked at one point in time rather than tracking patients over years, so we don’t know how quickly bones weakened. Fourth, the study didn’t examine whether patients received vitamin D supplements or other bone-protective treatments, which could affect results. Finally, the study couldn’t determine whether treating vitamin D deficiency would improve bone health in these patients.
The Bottom Line
For patients with muscular dystrophy requiring long-term hospitalization: (1) Doctors should regularly measure bone density and vitamin D levels—this is a moderate-confidence recommendation based on this study’s findings. (2) Vitamin D supplementation should be considered to bring levels above 30 ng/mL, though more research is needed to prove this prevents fractures. (3) Adequate calcium intake through diet or supplements is important. (4) Physical therapy and movement, even passive movement of limbs, may help preserve bone health, though this study doesn’t directly test this. These recommendations have moderate confidence because the study is small and observational.
This research is most relevant to: patients with muscular dystrophy in long-term care settings, their families and caregivers, and healthcare providers treating these patients. It’s less directly relevant to patients with muscular dystrophy who are still mobile or have shorter hospital stays, though some findings may apply. People with other conditions causing long-term immobility (spinal cord injury, severe cerebral palsy) may also benefit from similar bone health monitoring.
Bone loss develops gradually over months and years, so benefits from treatment would also take time. Vitamin D levels can improve within weeks of supplementation, but bone density improvements typically take 6-12 months to become measurable. Fracture prevention benefits may take even longer to demonstrate.
Frequently Asked Questions
Do people with muscular dystrophy in hospitals develop weak bones?
Yes. A 2026 study of 32 long-term hospitalized muscular dystrophy patients found severe hip bone weakness (T-score -4.1) and vitamin D deficiency (18.8 ng/mL). Prolonged immobility from wheelchair use or bed confinement appears to accelerate bone loss in this population.
What causes bone loss in hospitalized muscular dystrophy patients?
The combination of muscular dystrophy and years of immobility from wheelchair dependence or bed confinement causes bone loss. Low vitamin D levels (averaging 18.8 ng/mL in the study) also contribute. Weight-bearing exercise normally strengthens bones, so lack of movement weakens them over time.
Should hospitalized muscular dystrophy patients take vitamin D supplements?
Likely yes, based on this research showing vitamin D deficiency in 100% of long-term hospitalized patients. However, more studies are needed to prove supplements prevent fractures. Discuss vitamin D supplementation with your healthcare provider to determine appropriate doses.
How long does it take to develop weak bones from hospitalization?
The study patients had been hospitalized for a median of 2,287 days (over 6 years), suggesting bone loss develops gradually over years. Bone density changes typically take 6-12 months to measure, but the underlying process begins much earlier with immobility.
Can weak bones from hospitalization be reversed?
This study doesn’t directly address reversal, but research on immobility suggests bone loss can be slowed or partially reversed with adequate vitamin D, calcium, and movement (including passive physical therapy). Treatment effects typically take 6-12 months to show measurable improvements.
Want to Apply This Research?
- Track vitamin D supplementation doses and dates, plus any bone density test results (T-scores) with dates. Users can set monthly reminders to log vitamin D intake and quarterly reminders to note any bone-related symptoms like pain or falls.
- Set a daily reminder to take vitamin D supplements at the same time each day. Log the dose in the app to maintain consistency. For caregivers, use the app to schedule regular check-ins about bone health with healthcare providers and track when bone density tests are due.
- Create a long-term tracking dashboard showing: (1) vitamin D supplement adherence over months, (2) dates of bone density tests and T-score results, (3) any falls or bone pain incidents, (4) calcium intake from food and supplements. Review quarterly with healthcare providers to adjust treatment plans based on trends.
This research describes bone health patterns in hospitalized muscular dystrophy patients but does not establish definitive treatment protocols. The study is small (32 patients) and observational, so findings may not apply to all patients. If you or a loved one has muscular dystrophy and concerns about bone health, consult with a healthcare provider before starting supplements or making treatment changes. This article is for educational purposes and should not replace professional medical advice. Bone density testing and vitamin D level measurement should be ordered by a qualified physician.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.